Acute effects of betahistine hydrochloride on food intake and appetite in obese women: A randomized, placebo-controlled trial

American Journal of Clinical Nutrition

Volumn 92, Issue 6, 2010, Pages 1290-1297

  Ali, Asem H ^a,b   Yanoff, Lisa B ^a   Stern, Elizabeth A ^a   Akomeah, Abena ^a   Courville, Amber ^c   Kozlosky, Merel ^c   Brady, Sheila M ^a   Calis, Karim A ^a   Reynolds, James C ^c   Crocker, Melissa K ^a   Barak, Nir ^d,e   Yanovski, Jack A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

^e Obecure Ltd   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETAHISTINE;

ADULT; APPETITE; ARTICLE; CALORIC INTAKE; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; FOOD INTAKE; HUMAN; HUNGER; MAJOR CLINICAL STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL; SATIETY; TEST MEAL;

ADULT; APPETITE REGULATION; BETAHISTINE; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; HUMANS; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; SATIATION;

ANIMALIA;

EID: 78651291604     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.001586     Document Type: Article

References (34)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
2. Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health (Larchmt) 2003;12:163-72.
3. Ryan D. Obesity in women: a life cycle of medical risk. Int J Obes (Lond) 2007;31(suppl 2):S3-7; discussion S31-2. (Pubitemid 350023167)
4. Zavorsky GS. Cardiopulmonary aspects of obesity in women. Obstet Gynecol Clin North Am 2009;36:267-84, viii.
5. Sakata T, Yoshimatsu H, Kurokawa M. Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism. Nutrition 1997;13:403-11. (Pubitemid 27282131)
6. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983;302:832-7.
7. Van Cauwenberge PB, De Moor SE. Physiopathology of H3-receptors and pharmacology of betahistine. Acta Otolaryngol Suppl 1997;526:43-6.
8. Clineschmidt BV, Lotti VJ. Histamine: intraventricular injection suppresses ingestive behavior of the cat. Arch Int Pharmacodyn Ther 1973;206:288-98.
9. Itowi N, Nagai K, Nakagawa H, Watanabe T, Wada H. Changes in the feeding behavior of rats elicited by histamine infusion. Physiol Behav 1988;44:221-6. (Pubitemid 18261212)
10. Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. Diabetes 2001;50:376-84. (Pubitemid 32127295)
11. Lecklin A, Tuomisto L, MacDonald E. Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats. Methods Find Exp Clin Pharmacol 1995;17:47-52.
12. Sakata T. Hypothalamic neuronal histamine modulates energy balance in rats. Agents Actions Suppl 1991;33:91-6.
13. Ookuma K, Sakata T, Fukagawa K, et al. Neuronal histamine in the hypothalamus suppresses food intake in rats. Brain Res 1993;628:235-42.
14. Fukagawa K, Sakata T, Shiraishi T, et al. Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus. Am J Physiol 1989;256:R605-11.
15. Masaki T, Chiba S, Yasuda T, et al. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 2004;53:2250-60.
16. Kasaoka S, Kawahara Y, Inoue S, et al. Gender effects in dietary histidine-induced anorexia. Nutrition 2005;21:855-8.
17. Gotoh K, Masaki T, Chiba S, et al. Hypothalamic neuronal histamine signaling in the estrogen deficiency-induced obesity. J Neurochem 2009;110:1796-805.
18. Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985;111:73-84. (Pubitemid 15097843)
19. Fossati A, Barone D, Benvenuti C. Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res 2001;43:389-92. (Pubitemid 32607771)
20. Jeck-Thole S, Wagner W. Betahistine: a retrospective synopsis of safety data. Drug Saf 2006;29:1049-59. (Pubitemid 44912713)
21. Rossi R, Del Prete E, Scharrer E. Effect of the H1-histamine receptor agonist betahistine on drinking and eating behavior in pygmy goats. Physiol Behav 1999;66:517-21. (Pubitemid 29219449)
22. Szelag A, Trocha M, Merwid-Lad A. Betahistine inhibits food intake in rats. Pol J Pharmacol 2001;53:701-7. (Pubitemid 34065782)
23. Barak N, Greenway FL, Fujioka K, Aronne LJ, Kushner RF. Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. Int J Obes (Lond) 2008;32:1559-65.
24. Poyurovsky M, Pashinian A, Levi A, Weizman R, Weizman A. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int Clin Psychopharmacol 2005;20:101-3. (Pubitemid 40354400)
25. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-53.
26. Gluck ME, Geliebter A, Satov T. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients. Obes Res 2001;9:264-7. (Pubitemid 33603846)
27. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83. (Pubitemid 15134378)
28. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990;51:241-7.
29. Yanovski SZ, Leet M, Yanovski JA, et al. Food selection and intake of obese women with binge-eating disorder. Am J Clin Nutr 1992;56:975-80 (Published erratum appears in Am J Clin Nutr 1993;57:456.)
30. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000;24:38-48.
31. Faul F, Erfelder E. GPOWER: A priori, post-hoc, and compromize power analyses for MS-DOS. Bonn, Germany: Bonn University Department of Psychology, 1992.
32. Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003;28:519-26.
33. Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH. Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci USA 2007;104:3456-9.
34. Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999;60:358-63.